Switch to:
More From Other Websites
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis May 22 2017
Top trades from SALT May 18 2017
Incyte Teams Up With Dow's Merck To Trounce Roche In Cancer May 18 2017
Merck says test shows Keytruda improves survival for bladder cancer patients May 17 2017
Roche Seeks to Mend Damaged Nerves in Multiple Sclerosis Push May 17 2017
Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study May 12 2017
Inovio (INO) Q1 Loss Narrower Than Expected, Revenues Beat May 11 2017
Genentech to Present New Data on Personalized Medicines and Cancer Immunotherapies at the 2017... May 11 2017
Why Roche's Cancer Failure Might Tank Bristol, Pfizer — But Not Merck May 10 2017
Cancer Immunotherapy Fallout From Roche's Bladder Cancer Failure May 10 2017
Roche Throws a New Wrinkle Into the IO Market May 10 2017
Roche's Loss In Bladder Cancer Lifts Astrazeneca and Could Boost Bristol-Myers May 10 2017
Genentech Provides Update on Phase III Study of TECENTRIQ (Atezolizumab) in People with Previously... May 10 2017
The Zacks Analyst Blog Highlights: Arcelor Mittal, Roche Holding AG and Cummins May 09 2017
Biogen Inc. -- Moody's revised Biogen's outlook to stable; affirms Baa1 May 03 2017
Exelixis (EXEL) Posts Earnings in Q1, Cabometyx in Focus May 02 2017
Roche receives FDA approval for complementary PD-L1 (SP263) biomarker test in urothelial carcinoma May 02 2017
FDA clears Roche high-volume immunoassay lab testing solution to support critical medical treatment... May 01 2017
AstraZeneca Wallops Profit Views Despite Toppling Sales; Eyes Key Trial Apr 27 2017
[$$] Roche Revenue Up 4% Apr 27 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK